255 – GE Mosquito Release in Florida




Talking Biotech Podcast show

Summary: <br> <a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.talkingbiotechpodcast.com%2F255-ge-mosquito-release-in-florida%2F&amp;via=talkingbiotech" class="twitter-share-button" data-size="large">Tweet</a><br> <a href="https://i0.wp.com/www.talkingbiotechpodcast.com/wp-content/uploads/2020/08/255-oxitec2.jpg"></a><br> Florida is the canary in the coalmine for mosquito-transmitted disease in the USA.  The Florida Keys are especially vulnerable.  Traffic through this sensitive string of islands allows infected insects to be rapidly vectored to other areas of the keys, as well as to the mainland.  Over the last decade there have been notable incidents of Zika, Chikunguna, Denge and other mosquito-borne diseases. Over the same time a self-limiting mosquito technology has been developed by Oxitec. The mosquitoes have been programmed with genetic changes that render the next generation unable to develop, and it has been extremely successful in Brazil and other locations. The technology is now poised for release in the keys and has received all needed approvals. Today’s podcast speaks with Meredith Fensom, the Head of Global Public Affairs with Oxitec. She discusses the technology, the release in Florida, and its potential risks and benefits.<br> <a href="https://www.oxitec.com/florida">Here’s Oxitec’s website for the Florida Keys </a>  — There are MANY resources here on this page, too much to list. If you have questions you’ll find  an answer here.<br> And of course, I’m always glad to answer your questions.  Kevin<br>  <br>  <br>